Renaissance Technologies
OMIC

Renaissance Technologies’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Renaissance Technologies’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,707
Closed -$57K – 4073
2024
Q1 		$57K Sell
3,707
-1,341
-27% -$20.5K ﹤0.01% 3464
2023
Q4 		$70K Sell
5,048
-73
-1% -$864 ﹤0.01% 3387
2023
Q3 		$59K Buy
5,121
+1,464
+40% +$27.2K ﹤0.01% 3372
2023
Q2 		$91K Buy
3,657
+2,907
+388% +$85.2K ﹤0.01% 3500
2023
Q1 		$27K Buy
750
+100
+15% +$6.13K ﹤0.01% 3777
2022
Q4 		$39K Sell
650
-557
-46% -$37.3K ﹤0.01% 3849
2022
Q3 		$91K Sell
1,207
-516
-30% -$53.9K ﹤0.01% 3624
2022
Q2 		$197K Sell
1,723
-1,457
-46% -$171K ﹤0.01% 3656
2022
Q1 		$602K Buy
+3,180
New +$736K ﹤0.01% 3065

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Renaissance Technologies's OMIC Position: Q2 2024 in Review

Renaissance Technologies sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 3,707 shares — an estimated $57K sold.

Renaissance Technologies first reported a position in OMIC in Q1 2022 and held it in 9 quarters. The position peaked at $602K in Q1 2022. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Renaissance Technologies reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 3,707 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $57K.
  • Renaissance Technologies first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • Renaissance Technologies's Singular Genomics Systems, Inc. Common Stock position peaked at $602K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.